新型取代（Z）-5-((N-苄基-1H-吲哚-3-基)亚甲基)咪唑烷-2,4-二酮和 5-((N-苄基-1H-吲哚-3-基)亚甲基)嘧啶-2,4,6(1H,3H,5H)-三酮作为有效的放射增敏剂。
Novel substituted (Z)-5-((N-benzyl-1H-indol-3-yl)methylene)imidazolidine-2,4-diones and 5-((N-benzyl-1H-indol-3-yl)methylene)pyrimidine-2,4,6(1H,3H,5H)-triones as potent radio-sensitizing agents.
机构信息
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536-0082, USA.
出版信息
Bioorg Med Chem Lett. 2010 Jan 15;20(2):600-2. doi: 10.1016/j.bmcl.2009.11.082. Epub 2009 Nov 22.
Abstract
A series of (Z)-5-((N-benzyl-1H-indol-3-yl)methylene)imidazolidine-2,4-dione (9a-9m) and 5-((N-benzyl-1H-indol-3-yl)methylene)pyrimidine-2,4,6(1H,3H,5H)-trione (10a-10i) derivatives that incorporate a variety of aromatic substituents in both the indole and N-benzyl moieties have been synthesized. These analogs were evaluated for their radiosensitization activity against the HT-29 cell line. Three analogs, 10a, 10b, and 10c were identified as the most potent radiosensitizing agents.
摘要
一系列（Z）-5-((N-苄基-1H-吲哚-3-基)亚甲基)咪唑烷-2,4-二酮（9a-9m）和 5-((N-苄基-1H-吲哚-3-基)亚甲基)嘧啶-2,4,6(1H,3H,5H)-三酮（10a-10i）衍生物，其中吲哚和 N-苄基部分都包含了各种芳香取代基。这些类似物被评估了对 HT-29 细胞系的放射增敏活性。三种类似物，10a、10b 和 10c，被确定为最有效的放射增敏剂。
相似文献
1
Novel substituted (Z)-5-((N-benzyl-1H-indol-3-yl)methylene)imidazolidine-2,4-diones and 5-((N-benzyl-1H-indol-3-yl)methylene)pyrimidine-2,4,6(1H,3H,5H)-triones as potent radio-sensitizing agents.
Bioorg Med Chem Lett. 2010 Jan 15;20(2):600-2. doi: 10.1016/j.bmcl.2009.11.082. Epub 2009 Nov 22.
2
Synthesis and anti-proliferative activity of aromatic substituted 5-((1-benzyl-1H-indol-3-yl)methylene)-1,3-dimethylpyrimidine-2,4,6(1H,3H,5H)-trione analogs against human tumor cell lines.
Bioorg Med Chem Lett. 2014 Jan 15;24(2):601-3. doi: 10.1016/j.bmcl.2013.12.013. Epub 2013 Dec 9.
3
Microwave assisted synthesis and in vitro cytotoxicities of substituted (Z)-2-amino-5-(1-benzyl-1H-indol-3-yl)methylene-1-methyl-1H-imidazol-4(5H)-ones against human tumor cell lines.
Bioorg Med Chem Lett. 2010 Jan 15;20(2):591-3. doi: 10.1016/j.bmcl.2009.11.083. Epub 2009 Nov 22.
4
Synthesis, antimicrobial and anti-cancer activities of some new N-ethyl, N-benzyl and N-benzoyl-3-indolyl heterocycles.
Acta Pharm. 2012 Jun;62(2):157-79. doi: 10.2478/v10007-012-0020-3.
5
Synthesis and in vitro screening of novel N-benzyl aplysinopsin analogs as potential anticancer agents.
Bioorg Med Chem Lett. 2011 Mar 1;21(5):1411-3. doi: 10.1016/j.bmcl.2011.01.020. Epub 2011 Jan 11.
6
Synthesis, antimicrobial, anticancer evaluation and QSAR studies of 6-methyl-4-[1-(2-substituted-phenylamino-acetyl)-1H-indol-3-yl]-2-oxo/thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid ethyl esters.
Eur J Med Chem. 2012 Feb;48:16-25. doi: 10.1016/j.ejmech.2011.11.028. Epub 2011 Nov 22.
7
Synthesis and biological activity of some new 1-benzyl and 1-benzoyl-3-heterocyclic indole derivatives.
Acta Pharm. 2010 Mar;60(1):55-71. doi: 10.2478/v10007-010-0004-0.
8
Evaluation of newly synthesized 2-(thiophen-2-yl)-1H-indole derivatives as anticancer agents against HCT-116 cell proliferation via cell cycle arrest and down regulation of miR-25.
Sci Rep. 2024 Aug 29;14(1):20045. doi: 10.1038/s41598-024-68815-8.
9
Novel inhibitors of epidermal growth factor receptor: (4-(Arylamino)-7H-pyrrolo[2,3-d]pyrimidin-6-yl)(1H-indol-2-yl)methanones and (1H-indol-2-yl)(4-(phenylamino)thieno[2,3-d]pyrimidin-6-yl)methanones.
Bioorg Med Chem. 2012 Jan 1;20(1):125-36. doi: 10.1016/j.bmc.2011.11.023. Epub 2011 Nov 20.
10
Synthesis and cytotoxic potency of novel tris(1-alkylindol-3-yl)methylium salts: role of N-alkyl substituents.
Bioorg Med Chem. 2010 Sep 15;18(18):6905-13. doi: 10.1016/j.bmc.2010.07.025. Epub 2010 Jul 23.
引用本文的文献
1
Recent Development in Hydantoins, Thiohydantoins, and Selenohydantoins as Anticancer Agents: Structure-activity Relationship and Design Strategies.
Mini Rev Med Chem. 2025;25(9):693-726. doi: 10.2174/0113895575329643241206101210.
2
Targeting NPM1 in irradiated cells inhibits NPM1 binding to RAD51, RAD51 foci formation and radiosensitizes NSCLC.
Cancer Lett. 2021 Mar 1;500:220-227. doi: 10.1016/j.canlet.2020.12.023. Epub 2020 Dec 21.
3
Synthesis, anti-microbial activity, cytotoxicity of some novel substituted (5-(3-(1H-benzo[d]imidazol-2-yl)-4-hydroxybenzyl)benzofuran-2-yl)(phenyl)methanone analogs.
Chem Cent J. 2018 Jan 9;12(1):1. doi: 10.1186/s13065-017-0364-3.
4
In Vitro and in Vivo Effects of Nitrofurantoin on Experimental Toxoplasmosis.
Korean J Parasitol. 2016 Apr;54(2):155-61. doi: 10.3347/kjp.2016.54.2.155. Epub 2016 Apr 30.
5
Molecules that target nucleophosmin for cancer treatment: an update.
Oncotarget. 2016 Jul 12;7(28):44821-44840. doi: 10.18632/oncotarget.8599.
6
1-Benzyl-2-methyl-3-indolylmethylene barbituric acid derivatives: Anti-cancer agents that target nucleophosmin 1 (NPM1).
Bioorg Med Chem. 2015 Nov 15;23(22):7226-33. doi: 10.1016/j.bmc.2015.10.019.
7
Synthesis and dynamics studies of barbituric acid derivatives as urease inhibitors.
Chem Cent J. 2015 Nov 17;9:63. doi: 10.1186/s13065-015-0140-1. eCollection 2015.
8
Development and validation of a novel assay to identify radiosensitizers that target nucleophosmin 1.
Bioorg Med Chem. 2015 Jul 1;23(13):3681-6. doi: 10.1016/j.bmc.2015.04.018. Epub 2015 Apr 11.
9
N-Aroyl indole thiobarbituric acids as inhibitors of DNA repair and replication stress response polymerases.
ACS Chem Biol. 2013 Aug 16;8(8):1722-9. doi: 10.1021/cb400305r. Epub 2013 May 28.
10
5-((1-Aroyl-1H-indol-3-yl)methylene)-2-thioxodihydropyrimidine-4,6(1H,5H)-diones as potential anticancer agents with anti-inflammatory properties.
Bioorg Med Chem Lett. 2013 Mar 1;23(5):1442-6. doi: 10.1016/j.bmcl.2012.12.053. Epub 2012 Dec 22.
本文引用的文献
1
Radiosensitization of HT-29 cells and xenografts by the nitric oxide donor DETANONOate.
J Surg Oncol. 2009 Aug 1;100(2):149-58. doi: 10.1002/jso.21318.
2
Cancer statistics, 2008.
CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96. doi: 10.3322/CA.2007.0010. Epub 2008 Feb 20.
3
Long-term results of salvage radiotherapy for the treatment of recurrent cervical carcinoma after prior surgery.
Radiother Oncol. 2008 Nov;89(2):197-204. doi: 10.1016/j.radonc.2008.01.004. Epub 2008 Jan 30.
4
Novel substituted (Z)-2-(N-benzylindol-3-ylmethylene)quinuclidin-3-one and (Z)-(+/-)-2-(N-benzylindol-3-ylmethylene)quinuclidin-3-ol derivatives as potent thermal sensitizing agents.
Bioorg Med Chem Lett. 2007 Dec 15;17(24):6821-4. doi: 10.1016/j.bmcl.2007.10.035. Epub 2007 Oct 17.
5
Phenotypic characterization of human colorectal cancer stem cells.
Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10158-63. doi: 10.1073/pnas.0703478104. Epub 2007 Jun 4.
6
Hyperthermia: a potent enhancer of radiotherapy.
Clin Oncol (R Coll Radiol). 2007 Aug;19(6):418-26. doi: 10.1016/j.clon.2007.03.015. Epub 2007 May 10.
7
Novel chemical enhancers of heat shock increase thermal radiosensitization through a mitotic catastrophe pathway.
Cancer Res. 2007 Jan 15;67(2):695-701. doi: 10.1158/0008-5472.CAN-06-3212.
8
How do cells respond to their thermal environment?
Int J Hyperthermia. 2005 Dec;21(8):681-7. doi: 10.1080/02656730500307298.
9
Radiotherapy and concurrent radiochemotherapy for rectal cancer.
Surg Oncol. 2004 Aug-Nov;13(2-3):93-101. doi: 10.1016/j.suronc.2004.08.012.
10
Local recurrence in the breast after conservative surgery--a study of prognosis and prognostic factors in 391 women.
Eur J Cancer. 2002 Sep;38(14):1860-70. doi: 10.1016/s0959-8049(02)00219-8.
Zotero 插件